Related Experiment Video
Updated: May 4, 2026

HPLC Coupled with Chemical Fingerprinting for Multi-Pattern Recognition for Identifying the Authenticity of Clematidis Armandii Caulis
Published on: November 11, 2022
Five new clerodane diterpenoids from Callicarpa integerrima and their anti-inflammatory activity
Muhammad Aurang Zeb1, Jian-Lin Lai1, Xing-Jie Zhang1
1Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education, Yunnan Characteristic Plant Extraction Laboratory Co., Ltd., Yunnan Key Laboratory of Research and Development for Natural Products, School of Chemical Science and Technology, School of Pharmacy, and School of Life Sciences, Yunnan University, Kunming 650500, PR China.
Five new compounds from Callicarpa integerrima show potent anti-inflammatory effects. Compound 3 significantly inhibits lactate dehydrogenase (LDH) release and NLRP3 inflammasome activation, reducing pyroptosis.
Area of Science:
- Natural Products Chemistry
- Pharmacology
- Immunology
Background:
- Callicarpa integerrima is a plant source of bioactive compounds.
- Inflammasomes, particularly NLRP3, are key regulators of inflammation and pyroptosis.
- Pyroptosis is a pro-inflammatory form of programmed cell death.
Purpose of the Study:
- To isolate and characterize new clerodane diterpenoids from Callicarpa integerrima.
- To evaluate the anti-inflammatory potential of isolated compounds, focusing on pyroptosis and inflammasome activation.
Main Methods:
- Isolation of compounds using chromatographic techniques.
- Structure elucidation via NMR, HR-ESI-MS, IR, UV, specific rotations, ECD, and computational analysis.
- In vitro assays to measure LDH release, IL-1β suppression, and ASC speck formation.
Main Results:
- Five new clerodane diterpenoids, calintegerinoids A-E, were identified.
- Compound 3 exhibited potent inhibition of LDH release (IC50 = 1.27 μM) compared to Andrographolide (IC50 = 8.01 μM).
- Compound 3 suppressed IL-1β release, blocked NLRP3 inflammasome activation, and reduced pyroptosis and ASC speck formation.
Conclusions:
- Calintegerinoids A-E are novel clerodane diterpenoids from Callicarpa integerrima.
- Compound 3 displays significant anti-inflammatory properties by inhibiting NLRP3 inflammasome assembly and pyroptosis.
- This study highlights the therapeutic potential of compound 3 for inflammatory diseases.
More Related Videos
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
12:34Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
Published on: January 12, 2024
Related Concept Videos
Inflammation
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF